GREGORY SARGEN
CIK 1227835 · CFO & EVP, Corp. Dev. · last filed 2026-06-16
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$123.4K
Companies
5
Total Filings
49
Lifetime Open-Market Net
-$23.46M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TARA | Director | 31,000 | $3.98 | $123.4K | $0 | 8 | 2026-06-16 |
| Avid Bioservices, Inc. (CDMO) Delisted | Director | 36,368 | $12.49 | $454.2K | -$141.9K | 5 | 2024-12-17 |
| Avid Bioservices, Inc. (CDMOP) Delisted | Director | — | $25.06 | — | $0 | 3 | 2020-12-16 |
| CAMBREX CORP (CBM) Delisted | CFO & EVP, Corp. Dev. | 0 | — | — | -$23.31M | 31 | 2019-12-05 |
| Avid Bioservices, Inc. (PPHMP) Delisted | Director | — | — | — | $0 | 1 | 2017-11-29 |
Recent Filings · Page 3 of 5
49 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-10-26 | CAMBREX CORP (CBM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-09 | CAMBREX CORP (CBM) Delisted | Mixed | — | -$2.15M | EDGAR |
| 2017-11-29 | Avid Bioservices, Inc. (PPHMP) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-11-01 | CAMBREX CORP (CBM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-02-08 | CAMBREX CORP (CBM) Delisted | Mixed | — | -$1.65M | EDGAR |
| 2016-11-14 | CAMBREX CORP (CBM) Delisted | Mixed | — | -$816.6K | EDGAR |
| 2016-10-28 | CAMBREX CORP (CBM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2016-03-11 | CAMBREX CORP (CBM) Delisted | Sell (S) | +26,697 | $1.10M | EDGAR |
| 2016-02-12 | CAMBREX CORP (CBM) Delisted | Mixed | +13,378 | -$492.5K | EDGAR |
| 2015-11-16 | CAMBREX CORP (CBM) Delisted | Mixed | — | -$1.02M | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.